Showing results (1-10 of 179) with videos related to
Sort By:
Pageof 18
Neuron|April 19, 2014
Muscle matters in Kennedy's diseaseCarlo Rinaldi, Laura C Bott, Kenneth H FischbeckJournal of Visualized Experiments : Jove|August 28, 2018
Systemic Delivery of MicroRNA Using Recombinant Adeno-associated Virus Serotype 9 to Treat Neuromuscular Diseases in RodentsNaemeh Pourshafie, Philip R Lee, Ke-Lian Chen, et al.Molecular Medicine (Cambridge, Mass.)|September 7, 2012
Insulinlike growth factor (IGF)-1 administration ameliorates disease manifestations in a mouse model of spinal and bulbar muscular atrophyCarlo Rinaldi, Laura C Bott, Ke-lian Chen, et al.Biochemistry and Biophysics Reports|November 11, 2017
The polyglutamine-expanded androgen receptor has increased DNA binding and reduced transcriptional activitySergey Belikov, Laura C Bott, Kenneth H Fischbeck, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|January 13, 2016
MiR-298 Counteracts Mutant Androgen Receptor Toxicity in Spinal and Bulbar Muscular AtrophyNaemeh Pourshafie, Philip R Lee, Ke-Lian Chen, et al.Neurobiology of Disease|June 14, 2014
Stem cell-derived motor neurons from spinal and bulbar muscular atrophy patientsChristopher Grunseich, Kristen Zukosky, Ilona R Kats, et al.Scientific Reports|June 18, 2016
The polyglutamine-expanded androgen receptor responsible for spinal and bulbar muscular atrophy inhibits the APC/C(Cdh1) ubiquitin ligase complexLaura C Bott, Florian A Salomons, Dragan Maric, et al.Human Molecular Genetics|March 11, 2016
A small-molecule Nrf1 and Nrf2 activator mitigates polyglutamine toxicity in spinal and bulbar muscular atrophyLaura C Bott, Nisha M Badders, Ke-Lian Chen, et al.Journal of Molecular Neuroscience : MN|November 9, 2015
Spinal and Bulbar Muscular Atrophy OverviewKenneth H FischbeckProgress in Neurobiology|June 7, 2012
Developing treatment for spinal and bulbar muscular atrophyKenneth H FischbeckPageof 18